title: A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
abstract: Earlier studies showed that purified IgG from sera of rabbits immunized with a boiled Escherichia coli J5 (Rc chemotype) whole cell vaccine protected neutropenic rats against gram-negative bacterial sepsis. In the present study, de-O-acylated J5 lipopolysaccharide (J5 DLPS) as a noncovalent complex with Neisseria meningitidis group B outer membrane protein (GBOMP) elicited anti-J5 LPS antibodies in rabbits. IgG prepared from immune rabbit sera protected neutropenic rats against lethal challenge with Pseudomonas aeruginosa 12:4:4 (Fisher Devlin immunotype 6). Sixteen of 26 rats treated with the postimmune serum IgG were protected compared with none of 20 rats treated with the control rabbit serum IgG (P < .001). In vitro binding studies showed binding of anti-J5 IgG to several gram-negative bacteria. These results indicate that a subunit vaccine made of J5 DLPS as a noncovalent complex with GBOMP may protect against gram-negative bacteremia.
authors.affiliation: Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC 20307-5100, USA.
authors.forename: A K
authors.initials: AK
authors.lastname: Bhattacharjee
authors.forename: S M
authors.initials: SM
authors.lastname: Opal
authors.forename: R
authors.initials: R
authors.lastname: Taylor
authors.forename: R
authors.initials: R
authors.lastname: Naso
authors.forename: M
authors.initials: M
authors.lastname: Semenuk
authors.forename: W D
authors.initials: WD
authors.lastname: Zollinger
authors.forename: E E
authors.initials: EE
authors.lastname: Moran
authors.forename: L
authors.initials: L
authors.lastname: Young
authors.forename: C
authors.initials: C
authors.lastname: Hammack
authors.forename: J C
authors.initials: JC
authors.lastname: Sadoff
authors.forename: A S
authors.initials: AS
authors.lastname: Cross
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D000918:Antibody Specificity; D016470:Bacteremia / Q000276:immunology / Q000517:prevention & control*; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000276:immunology*; D004731:Endotoxins / Q000097:blood; D004926:Escherichia coli / Q000276:immunology*; D004927:Escherichia coli Infections / Q000276:immunology; D022361:Escherichia coli Vaccines; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000276:immunology / Q000517:prevention & control*; D007106:Immune Sera / Q000276:immunology; D007116:Immunization, Passive; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D008070:Lipopolysaccharides / Q000737:chemistry / Q000276:immunology*; D009345:Neisseria meningitidis / Q000276:immunology*; D011552:Pseudomonas Infections / Q000517:prevention & control; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D018074:Vaccines, Conjugate / Q000276:immunology
chemical_list: D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D004731:Endotoxins; D022361:Escherichia coli Vaccines; D007106:Immune Sera; D007074:Immunoglobulin G; D008070:Lipopolysaccharides; D018074:Vaccines, Conjugate